Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 11/16/15 → 10/17/18 |
Funding
- Pharmaceutical Research Associates Incorporated: $36,494.00
Astrazeneca: A Phase I, Open-Label, Multicentre Study to Assess the Safety, Tolerability and Efficacy of Olaparib in Combination with Carboplatin Comprising: Part A: Dose Escalation of Olaparib in Combination Carboplatin in Patients with ..
- Baer, Lea (PI)
- Cohen, Jules A (CoPI)
- Stopeck, Alison (CoPI)
- Kudelka, Andrzej (CoPI)
Project: Research